Wave Life Sciences Ltd.
WVE
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins, or modulate protein expression. The company aā¦ read more
Healthcare
Biotechnology
10 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$13.02
Price-2.47%
-$0.33
1Y
Price
Market Cap
$2.451b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-295.3%
EBITDA Margin-308.4%
Net Profit Margin-186.2%
Free Cash Flow Margin-295.3%
EBITDA Margin-308.4%
Net Profit Margin-186.2%
Free Cash Flow MarginRevenue
$42.727m
-60.5%
1y CAGR+980.0%
3y CAGR+712.3%
5y CAGREarnings
-$204.378m
-110.7%
1y CAGR-38.3%
3y CAGR-36.8%
5y CAGREPS
-$1.21
-74.3%
1y CAGR-10.1%
3y CAGR-4.3%
5y CAGRBook Value
$526.231m
$638.499m
Assets$112.268m
Liabilities$17.766m
DebtDebt to Assets
2.8%
-0.1x
Debt to EBITDAFree Cash Flow
-$187.493m
-22.8%
1y CAGR-192.8%
3y CAGR-155.6%
5y CAGRNo items found.
Press Releases
Statements and updates from the company